In August 2021, the company closed an upsize $80 million Collection B funding round, funded by many enterprise cash investors. With this funding, Beckley Psytech will proceed to operate to expand and progress its enhancement pipeline. PharmaTher is granted orphan drug designation for its enhancement software centered on managing https://halles961voe8.ttblogs.com/profile